In late 2022, Blue Matter’s London team hosted a meeting attended by representatives from more than 15 biotech companies in the Oxford biotech sector. These companies included relatively new start-ups, technology platform companies, and established biotech firms. The representatives were primarily C-suite leaders who came together to discuss goals, challenges, and potential solutions across a range of topic areas. This paper provides a detailed summary of the discussions
